Literature DB >> 21117662

The synucleins are a family of redox-active copper binding proteins.

Paul Davies1, Xiaoyan Wang, Claire J Sarell, Alex Drewett, Frank Marken, John H Viles, David R Brown.   

Abstract

Thermodynamic studies in conjunction with EPR confirm that α-synuclein, β-synuclein, and γ-synuclein bind copper(II) in a high affinity 1:1 stoichiometry. γ-Synuclein demonstrates the highest affinity, in the picomolar range, while α-synuclein and β-synuclein both bind copper(II) with nanomolar affinity. The copper center on all three proteins demonstrates reversible or partly reversible redox cycling. Various mutations show that the primary coordinating ligand for copper(II) is located within the N-terminal regions between residues 2-9. There is also a contribution from the C-terminus in conjunction with the histidine at position 50 in α-synuclein and position 65 in β-synuclein, although these regions appear to have little effect on overall coordination stability. These histidines and the C-terminus, however, appear to be critical to the redox engine of the proteins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21117662     DOI: 10.1021/bi101582p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  Membrane insertion exacerbates the α-Synuclein-Cu(II) dopamine oxidase activity: Metallothionein-3 targets and silences all α-synuclein-Cu(II) complexes.

Authors:  Jenifer S Calvo; Neha V Mulpuri; Alex Dao; Nabeeha K Qazi; Gabriele Meloni
Journal:  Free Radic Biol Med       Date:  2020-07-23       Impact factor: 7.376

Review 2.  Copper-dependent regulation of NMDA receptors by cellular prion protein: implications for neurodegenerative disorders.

Authors:  Peter K Stys; Haitao You; Gerald W Zamponi
Journal:  J Physiol       Date:  2012-02-06       Impact factor: 5.182

3.  The Rich Electrochemistry and Redox Reactions of the Copper Sites in the Cellular Prion Protein.

Authors:  Feimeng Zhou; Glenn L Millhauser
Journal:  Coord Chem Rev       Date:  2012-05-04       Impact factor: 22.315

4.  Alpha-synuclein functions in the nucleus to protect against hydroxyurea-induced replication stress in yeast.

Authors:  Xianpeng Liu; Yong Joo Lee; Liang-Chun Liou; Qun Ren; Zhaojie Zhang; Shaoxiao Wang; Stephan N Witt
Journal:  Hum Mol Genet       Date:  2011-06-03       Impact factor: 6.150

5.  α-Synuclein protects neurons from apoptosis downstream of free-radical production through modulation of the MAPK signalling pathway.

Authors:  Ruth E J Musgrove; Anna E King; Tracey C Dickson
Journal:  Neurotox Res       Date:  2012-08-31       Impact factor: 3.911

Review 6.  Autophagy in Neurodegenerative Diseases and Metal Neurotoxicity.

Authors:  Ziyan Zhang; Mahfuzur Miah; Megan Culbreth; Michael Aschner
Journal:  Neurochem Res       Date:  2016-02-11       Impact factor: 3.996

7.  Coordination of copper to the membrane-bound form of α-synuclein.

Authors:  Christopher G Dudzik; Eric D Walter; Benjamin S Abrams; Melissa S Jurica; Glenn L Millhauser
Journal:  Biochemistry       Date:  2012-12-26       Impact factor: 3.162

8.  Salivary antigen-5/CAP family members are Cu2+-dependent antioxidant enzymes that scavenge O₂₋. and inhibit collagen-induced platelet aggregation and neutrophil oxidative burst.

Authors:  Teresa C F Assumpção; Dongying Ma; Alexandra Schwarz; Karine Reiter; Jaime M Santana; John F Andersen; José M C Ribeiro; Glenn Nardone; Lee L Yu; Ivo M B Francischetti
Journal:  J Biol Chem       Date:  2013-04-05       Impact factor: 5.157

Review 9.  Wilson's disease and other neurological copper disorders.

Authors:  Oliver Bandmann; Karl Heinz Weiss; Stephen G Kaler
Journal:  Lancet Neurol       Date:  2015-01       Impact factor: 44.182

10.  The anticholinesterase phenserine and its enantiomer posiphen as 5'untranslated-region-directed translation blockers of the Parkinson's alpha synuclein expression.

Authors:  Sohan Mikkilineni; Ippolita Cantuti-Castelvetri; Catherine M Cahill; Amelie Balliedier; Nigel H Greig; Jack T Rogers
Journal:  Parkinsons Dis       Date:  2012-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.